Barclays Is Boosting Teva's PT
April 09, 2015 at 16:01 PM EDT
Barclays raised its price target on Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) Thursday to $80 and maintained an ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.